Doggett Announces Ways & Means Medicare Drug-Pricing Hearing
Published by Inside Health Policy
The House Ways & Means health subcommittee will hold a hearing on promoting competition to lower prescription drug prices in Medicare on March 7, chair Rep. Lloyd Doggett (D-TX) announced Thursday (Feb. 28). The committee is the latest to join the congressional dogpile of hearings on the issue, including a two-day Senate Special Committee on Aging hearing, of which the second session will be held on the same day.
Allowing Medicare to directly negotiate drug prices was a topic of heated discussion during the full Ways & Means drug-pricing hearing on Feb. 12. Overall committee ranking Republican Rep. Kevin Brady (TX) came out staunchly against the proposal. Doggett promoted his price-negotiation bill that includes compulsory licensing as an enforcement tool, but also maintained his stance that he is open to other negotiation models.
Doggett’s price-negotiation bill is the highest-profile proposal thus far with more than 100 House co-sponsors. It would allow HHS to negotiate prices for all Medicare Part D drugs, though Republicans largely inquired about how to address the costs of expensive, single-source drugs. — Rachel Cohrs (rcohrs@iwpnews.com)
Click here to see the original article on the Inside Health Policy website.
Recent Posts
- 
					 
					
						New Report Demonstrates Worsening Impact of Medicare Part D Negotiated Drug Prices on Long-Term Care Pharmacies and the Vulnerable Seniors They ServeHarbinger of deepening long-term care crisis in 2026 unless Congress swiftly passes essential LTC Pharmacy Fix Washington, D.C. — The Senior Care Pharmacy Coalition (SCPC), the national voice for the long-term care (LTC) pharmacy sector, today released the Economic Impact of Medicare Part D Negotiated Drug Prices on Long-Term Care Pharmacy Economics, with analytics performed […] 
- 
					 
					
						Pharmacy Community Stands Together to Protect Seniors and Prevent a Long-Term Care CrisisThe Senior Care Pharmacy Coalition (SCPC), representing the nation’s long-term care pharmacies, the American Society of Consultant Pharmacists (ASCP), representing pharmacists and pharmacies dedicated to managing medications for older adults and medically complex patients, and the National Community Pharmacists Association (NCPA), representing community pharmacists nationwide, stand united in support of immediate action—whether through legislation or […] 
- 
					 
					
						Rep. Beth Van Duyne: Congress can save seniors’ access to medications before it’s too lateSeniors in nursing homes across the country depend on round-the-clock care and medications, perhaps more than any other American patient population. In turn, the nursing homes and assisted living facilities that care for them depend on a small number of specialized long-term care (LTC) pharmacies to ensure their patients have access to the prescription meds they need. 
Stay in the Know
Get the latest news and updates on issues impacting the long-term pharmacy community.
